Addex Therapeutics Ltd logo

Addex Therapeutics Ltd

NEW
LTS:0QNV (Switzerland)  
CHF 0.040 (0%) Aug 14
At Loss
P/B:
1.40
Market Cap:
CHF 5.96M ($ 7.34M)
Enterprise V:
CHF 5.12M ($ 6.31M)
Volume:
0
Avg Vol (2M):
23.95K
Trade In:

Addex Therapeutics Ltd’s share price is CHF0.0398. Its GF Value is CHF0.01. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Addex Therapeutics Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: CHF0.0398 GF Value Price/GF Value
Current CHF0.01 3.98
Next FY1 End CHF0.01 3.98
Next 12 Month CHF0.01 3.98
Next FY2 End CHF0.01 3.98
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Addex Therapeutics Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Addex Therapeutics Ltd's stock price and Revenue per share, with a coefficient of 97%. This is followed by a 92% correlation with Book Value per share. Addex Therapeutics Ltd’s stock price shows no significant correlation with Earnings without NRI per share. Addex Therapeutics Ltd’s stock price shows no significant correlation with Operating Cash Flow per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies